ischaemia in the immediate postoperative period, and during recovery from anaesthetics remains to be determined. 11 12 Previous studies have shown that even concentrations of volatile anaesthetics as low as 0.1 MAC can signi®cantly reduce the response to hypercapnia and hypoxia. 13 14 We have studied this gene±environment interaction more closely using an inbred mouse model. Mice within an inbred strain are genetically identical but differ between strains based on genotype variation, which in¯uences physiological outcomes. C57BL/6J (B6) and C3H/HeJ (C3) mouse strains differ in their baseline breathing pattern and their response to hypercapnia. 15 16 Furthermore, the ®rst generation offspring (F 1 ) of B6 and C3 progenitors have been shown to resemble one or the other parental strain suggesting that breathing traits are heritable.
Therefore, we tested the effect of iso¯urane on respiratory rate (RR), tidal volume, and the response to hypercapnia in B6 compared with C3 mice and their F 1 progeny.
Methods

Animals
Our study protocol was approved by The Johns Hopkins Animal Care and Use Committee. Ten C57BL/6J (B6), 11 C3H/HeJ (C3), and 10 B6C3F1/J (F 1 ; i.e., female B6 crossed with male C3) male mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) and housed in the animal facilities at Johns Hopkins University for 5±7 weeks before the ®rst experiments. Water and chow (Agway Pro-Lab RMH 1000) were provided ad libitum. All experiments were performed at an age of 14 weeks (T10 days). Mean weight was 29.9 (3.4) g for B6, 31.9 (2.7) g for C3, and 33.7 (2.8) g for F 1 mice.
Measurements
Whole body plethysmograph Ventilatory function was assessed by whole body plethysmography under unrestrained conditions. 15 16 Each animal was permitted to acclimatize in a cylindrical chamber (400 cm 3 ) for at least 30 min before ventilation measurements were obtained. The chamber was placed in an insulated box to control environmental conditions (i.e. quiet and dark surroundings) and prevent heat loss. Chamber temperature was maintained within the thermoneutral zone for mice (26±28°C) and was recorded with each measurement using a type T thermocouple device. Hyperoxic air (oxygen 100%) was humidi®ed (90% relative humidity) and directed through the chamber at a¯ow rate of~300 ml min ±1 . At constant chamber volume, changes in pressure because of inspiration and expiration were measured using a differential pressure transducer (model 8510B-2, Endevco, San Juan Capistrano, CA, USA) and recorded on a strip chart recorder (Grass Polygraph model 7D, Grass Instrument Co., Quincy, MA, USA). The expired air at the outlet of the chamber was analysed for oxygen, carbon dioxide, nitrogen, and iso¯urane using a CAPNOMAC ULTRA ULT-V-27±06 (DATEX, Division of Instrumental Cooperation, Helsinki, Finland).
Protocol
When the animal was quiescent the chamber was sealed for 60 s to permit measurements of RR and the pressure amplitude (Amp; in mm) resulting from each tidal breath as a correlate of tidal volume. While the chamber was sealed metabolically, induced changes in carbon dioxide and oxygen were <1% of the target level.
Subsequently, gas with an inspired fraction of carbon dioxide 8% balanced with oxygen (Puritan-Bennett Medical Gases, Overland Park, KS, USA) was administered to the chamber for 6 min. At the end of this carbon dioxide challenge, measurements of RR and Amp were repeated as described above.
After these baseline measurements, iso¯urane (Abbott Laboratories, North Chicago, IL, USA) was added to inspired oxygen, via an agent-speci®c vaporizer integrated in the gas¯ow system. On different days B6, C3, or F 1 mice were studied in random order.
Iso¯urane was administered in increasing concentrations of 0.5, 1.0, and 1.5 MAC speci®c for C3 (1.5%) and B6 (1.30%) mice. 17 MAC for F 1 was taken as the average of B6 and C3 mice (1.40%). Iso¯urane was administered for 30 min at each concentration to achieve a steady state of anaesthesia. At steady state, measurements of RR and Amp were repeated and a carbon dioxide challenge was performed as described above.
Directly after the carbon dioxide challenge at the highest concentration of anaesthetic agent administered, the agent was turned off and the mice were observed during recovery from anaesthesia for the next 30 min. During the recovery period, measurements were performed at 5, 10, 20, and 30 min. At the end of the recovery the mice were challenged again with inspired carbon dioxide 8% for another 6 min.
Data analysis
Data are presented as mean (SD). The following a priori null hypotheses were tested: ®rst, there is no difference between B6 and C3 mice and their F 1 progeny in their breathing pattern during iso¯urane anaesthesia and in the recovery from anaesthesia; second, there is no strain difference between B6, C3, and F 1 mice in response to hypercapnia under the in¯uence of iso¯urane; and third, there is no strain difference in the response to hypercapnia between B6, C3, and F 1 mice during recovery from anaesthesia. Comparisons of RR and amplitude were separately analysed among strains controlling for anaesthetic concentration and carbon dioxide challenge using generalized ANOVA with Bonferroni's correction for multiple pair-wise comparisons. Signi®cant differences were considered to be P<0.05.
Results
Breathing pattern under the in¯uence of iso¯urane
At baseline, B6 mice showed a signi®cantly greater RR compared to C3 mice (P=0.0008) accompanied by signi®-cantly smaller tidal volumes (P=0.0016; Fig. 1 ). The F 1 offspring showed a RR similar to the B6 (P<0.0001, compared with C3 mice) and a tidal volume similar to the C3 progenitor (P=0.0119, compared with the B6 mice).
Increasing concentrations of iso¯urane led to decreased RR in each mouse strain to~17% of baseline (Fig. 1) . The RR response of each strain returned to baseline during the recovery period (Fig. 1) . Furthermore, increasing concentrations of iso¯urane anaesthesia initially blunted, and then abolished, the strain difference in RR response at baseline. At 0.5 MAC of iso¯urane, the only remaining signi®cant difference in RR was between C3 and F 1 mice (P=0.008). While at higher concentrations of iso¯urane, and during the recovery of anaesthesia, there was no signi®cant difference in RR between the three mouse strains.
Increasing concentrations of iso¯urane had mixed effects on Amp. At the highest concentration studied, there was a signi®cant increase in Amp in all strains (Fig. 2) . In addition, at 0.5 or 1.0 MAC Amp was signi®cantly smaller for B6 mice as compared with F 1 (P=0.008) or C3 mice (P=0.013, Fig. 2 ). At 1.5 MAC, there was no signi®cant difference among the three strains.
During recovery from anaesthesia, the strain difference in Amp between B6 and C3 was restored (P=0.0001) and was still maintained at 30 min of recovery (P=0.0002, Fig. 1 ) when the mice were considered completely recovered and subsequently returned to their cages.
Response to hypercapnia
Before iso¯urane anaesthesia, B6 mice responded with a signi®cantly greater carbon dioxide-induced increase in RR compared with either C3 (P=0.0093) or F 1 mice (P=0.0041). During iso¯urane anaesthesia, strain differences in RR in response to hypercapnia were abolished. However, there was no signi®cant difference in the carbon dioxide-induced increase in Amp among the three strains (Fig. 2) .
At 0.5 MAC, a signi®cant difference in carbon dioxideinduced breathing occurred between B6 and F 1 mice for RR and Amp (P=0.0001 and P=0.0036, respectively; Fig. 2 ). At higher concentrations of iso¯urane (1.0 and 1.5 MAC) the RR increase during hypercapnia was reduced (1.0 MAC) and abolished (1.5 MAC) in all three strains (Fig. 2) . In addition, the carbon dioxide-induced Amp responses decreased signi®cantly compared with pre-anaesthetic Amp responses for all mouse strains at 1.5 MAC abolishing the strain differences in Amp responses to hypercapnia.
At the end of recovery (30 min), while compared to their response at 1.5 MAC, the carbon dioxide-induced, augmented breathing was restored for both RR and Amp in B6 mice (Fig. 2) . However, compared with the baseline responses, the response in RR to hypercapnic challenge remained depressed. Furthermore, the carbon dioxideinduced responses of B6 mice were signi®cantly greater than the responses of both C3 and F 1 mice for RR (P<0.0001 and P=0.011, respectively) and for Amp (P=0.0001 and P=0.0016, respectively). In C3 and F 1 mice, there were no signi®cant increases in either RR or Amp for the hypercapnic challenge during recovery from anaesthesia. Exhaled iso¯urane concentrations during recovery did not show any signi®cant differences between the three mouse strains.
Discussion
In the current genetic model of breathing control, strain differences in breathing pattern and hypercapnic responses were completely abolished with clinically relevant concentrations of the inhalation anaesthetic iso¯urane. However, during emergence from anaesthesia, these genetically determined differences in respiratory drive were accentu- Genetic in¯uence on respiratory drive ated. The C3 parental strain, characterized by a blunted response to hypercapnia, continued to show a profound depression of their response to hypercapnia after iso¯urane anaesthesia. This phenotype was inherited by their F 1 progeny.
Inbred mouse strains are genetically identical and homozygous at every locus. 18 After extensive studies of breathing patterns and respiratory drive in different inbred mouse strains, two strains had been identi®ed as having two widely different phenotypes. The B6 strain, was characterized by a rapid and shallow baseline breathing pattern and a strong response to hypercapnia, while the C3 strain has a slow and deep baseline breathing pattern with a weak response to hypercapnia. 15 Studies of ®rst and second generations of B6 and C3 progenitors have suggested a relatively simple genetic model incorporating a few numbers of genes controlling each trait. 16 To explore the mechanisms controlling respiratory drive and the relevance of genetic variations under the in¯uence of central nervous system active agents, the current work examined the effects of a volatile anaesthetic agent on baseline breathing pattern and respiratory drive. We found in strains with signi®cantly different baseline breathing patterns and carbon dioxide responses while awake, that administration of clinically relevant iso¯urane concentrations dramatically affected each strain. The differences in RR among the two mouse strains and the F 1 progeny were eliminated at concentrations up to 1.5 MAC and during emergence. However, strain differences in tidal volume were essentially unaffected.
We consider the responses to hypercapnia as a model for postanaesthetic hypoventilation. At 0.5 MAC of iso¯urane, the response to carbon dioxide for both parental strains and the F 1 progeny was reduced. At 1.0 MAC, the lack of increase in RR was partially compensated for by an increase in tidal volume. At 1.5 MAC the response to carbon dioxide was entirely suppressed. At all concentrations of iso¯urane anaesthesia, strain differences between B6 and C3 mice in breathing responses to hypercapnic challenges were abolished.
In contrast, the effect of the low concentrations of iso¯urane during recovery showed signi®cant differences between the two strains and the F 1 progeny. More than 30 min after iso¯urane had been discontinued, the response to hypercapnia during recovery remained suppressed in C3 and F 1 mice, representing little to no change from the hypercapnic response at 1.5 MAC, while in B6 mice the carbon dixoide-induced RR and tidal volume responses increased signi®cantly. However, B6 responses did not return to the pre-anaesthetic levels even at the end of the recovery period.
It is noteworthy, that the responses in B6 mice were in accordance with results obtained in human volunteers inhaling 0.1 MAC iso¯urane in a silent room with dimmed light. 13 Van Elsen and colleagues demonstrated that controlling environmental conditions is a fundamental criterion in the study design. The response to hypoxia and hypercapnia varied signi®cantly with the state of arousal and were uncompromised when patients were kept awake with music or videos comparable to a noisy recovery room. 4 20 21 While the clinical relevance of an inherited predisposition to reduced respiratory drive may seem of only scienti®c interest in otherwise healthy individuals, it can be critically important during recovery from anaesthesia. Even at very low concentrations, volatile anaesthetic agents in combination with commonly administered potent analgesic medi- , and 10 C3B6F1/J (F 1 ) male mice measured at baseline; during 0.5, 1.0, and 1.5 MAC iso¯urane anaesthesia; and during recovery from anaesthesia at 30 min (RI±RIV) in response to a challenge with carbon dioxide 8% (mean (SD)). Compared with baseline, the increase in RR in response to hypercapnia was completely blocked at 1.0 and 1.5 MAC for all three strains (P<0.0001), while Amp increases slightly, but not signi®cantly, at 1.0 MAC, and was ®nally completely blocked at 1.5 MAC (B6 P=0.0068; C3 P=0.0003; and F 1 P=0.0043, compared with baseline). At the end of the recovery period, the B6 mice increased their RR signi®cantly compared with the response at 1.0 (P<0.0001) and 1.5 MAC (P<0.0001), and with the response of the C3 mice (P<0.0001) and the F 1 progeny (P=0.0110) mice. Furthermore, only B6 mice showed a signi®cant increase in Amp to the carbon dioxide challenge (P=0.0016), while the response of C3 and F 1 mice remained attenuated. cation can accentuate hypoventilation and further lead to ischaemic events. Our results demonstrate that genetic factors in¯uence the blunted hypercapnic responses in both C3 and F 1 mice suggesting a dominant inheritance pattern. Although the breathing pattern of F 1 mice at baseline resembled the pattern of B6 mice, their blunted carbon dioxide breathing phenotype at baseline was predictive of a blunted response to hypercarbia during recovery from anaesthesia.
Establishing genotypic markers for blunted respiratory drive would facilitate identifying patients at risk of postoperative hypoventilation. In the clinic, one could presumably adjust anaesthesia and postoperative care to decrease the risk of hypoventilation and thus prevent hypoxia and ischaemic events. There are groups of patients with obvious pathological breathing patterns and blunted respiratory drive, including patients with Pickwickian syndrome or other central apnoea syndromes. In these groups of patients, the increased risk for postoperative complications is well known and a matter of clinical concern. Greater clinical impact on patient safety is anticipated when patients with disturbances of respiratory drive that only became evident under the in¯uence of anaesthetics, sedatives, or analgesic drugs could be identi®ed a priori. 1 2 21 In conclusion, during iso¯urane anaesthesia, strain differences in breathing pattern and responses to hypercapnic challenge were abolished. However, during recovery from anaesthesia, a critical time for perioperative events, the carbon dioxide-induced response was restored only in B6 mice. In C3 and F 1 mice characterized by blunted carbon dioxide-induced responses, the response to hypercapnia remained depressed during recovery from anaesthesia. These results support a genetic basis for the increased risk of postanaesthetic hypoventilation and demonstrate the genetic predisposition to be heritable.
